organophosphonates has been researched along with 4-hydroxy-2-nonenal in 1 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (4-hydroxy-2-nonenal) | Trials (4-hydroxy-2-nonenal) | Recent Studies (post-2010) (4-hydroxy-2-nonenal) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 3,034 | 26 | 1,103 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arisawa, T; George, J; Hayashi, N; Hiratake, J; Tamura, K; Toshikuni, N; Tsuchishima, M; Tsutsumi, M | 1 |
1 other study(ies) available for organophosphonates and 4-hydroxy-2-nonenal
| Article | Year |
|---|---|
GGsTop, a novel and specific γ-glutamyl transpeptidase inhibitor, protects hepatic ischemia-reperfusion injury in rats.
Topics: Alanine Transaminase; Aldehydes; Aminobutyrates; Animals; Aspartate Aminotransferases; Cytoprotection; Disease Models, Animal; Enzyme Inhibitors; gamma-Glutamyltransferase; Glutathione; Interleukin-1beta; Liver; Liver Diseases; Male; Malondialdehyde; Necrosis; Organophosphonates; Oxidative Stress; Rats, Wistar; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2016 |